Quan Dong Nguyen, MD

Dr. Nguyen is Professor of Ophthalmology focusing on retinal diseases and Director of the Uveitis and Ocular Inflammation Service at the Byers Eye Institute at Stanford University School of Medicine. Dr. Nguyen is a recognized international authority in retinal diseases and uveitis who has served as Principal Investigator in numerous studies sponsored by the National Eye Institute, research foundations, and global drug development programs in the area of retinal disease and uveitis. His early-stage clinical work paved the way for the development of ranibizumab in diabetic macular edema /retinopathy and aflibercept in neovascular age-related macular degeneration; he also demonstrated the utility of interleukin inhibition in the management of uveitis and ocular inflammation.  Dr. Nguyen served previously as Chairman and Professor of Ophthalmology and Director of the Truhlsen Eye Institute and Assistant Dean for Translational Research at the University of Nebraska Medical Center, and Associate Professor of Ophthalmology and Director of Medical Education at the Wilmer Eye Institute, Johns Hopkins University.  Dr. Nguyen earned his BS and MSc at Yale University, MD at the University of Pennsylvania and completed his internship in internal medicine at the Massachusetts General Hospital, residency in ophthalmology as well as his retina and uveitis fellowships at the Massachusetts Eye and Ear Infirmary, Harvard Medical School, and his ocular immunology fellowship at the Wilmer Eye Institute.